Updated time: 2020-07-24 10:55:32
10T-1090713
2020-07-24
Know-how
Antibody affinity maturation technology is a method to enhance the binding of antibodies against antigens. Diversification of antibody genes is the initial step, of which there are three ways: (1) random mutation of antibody VH and VL, (2) antibody chain shuffling, and (3) sites-specific mutagenesis in CDR region. Then, the above antibody sequence repertoires were established as a phage display single-chain antibody library. Phage display technology was used to screen the target antigen molecules with different strategies and multiple strength combinations. It allows selection of antibodies with higher binding strength in a short time.
- Rapid, high throughput selection of high-affinity antibody.
- High success rate.
- Enhancement of antibody affinity by 2 to 100 folds.
- Enhancement of antibody affinity.
- Development of human antibodies for the treatment of disease.
- Development of antibodies for the diagnosis of disease.
Han-Chung Wu
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Antibody affinity maturation technology